Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Kashmir walnut (Juglans regia) is a nutrient-dense nut rich in bioactive polyphenols—including ellagic acid, gallic acid, quercetin, and juglone—that provide potent antioxidant, antimicrobial, and neuroprotective activity through iron chelation, hydroxyl radical scavenging, and PKA/CREB/BDNF pathway upregulation via the gut metabolite urolithin A. A comprehensive phytochemical review confirmed that J. regia contains over 50 pharmacologically active compounds with demonstrated cardioprotective, anti-inflammatory, antidiabetic, and anticancer properties (Bhat et al., 2023; PMID 36836737).
Reported Benefits (Provisional)
Origin & History
Kashmir Walnut (Juglans regia) is native to the temperate regions of Kashmir in northern India, thriving in its unique climate and rich soils. This prized nut is a cornerstone of regional cuisine and traditional medicine. It offers an exceptional profile of omega-3 fatty acids, antioxidants, and minerals, making it a powerful ingredient for functional nutrition, particularly for cognitive and cardiovascular health.
Research Narrative (Provisional)
A 2023 review in Life (Basel) catalogued the vital phytochemicals of Juglans regia, documenting polyphenols, tocopherols, and omega-3 fatty acids with cardioprotective, antidiabetic, and anticancer activities (Bhat et al., PMID 36836737). Rather et al. (2012) in Phytomedicine characterized the leaf essential oil of J. regia, identifying α-pinene, β-pinene, and β-caryophyllene as major constituents with significant antioxidant (DPPH IC₅₀ ~18 µg/mL) and antibacterial activity against S. aureus and E. coli (PMID 22951389). Ibrahim et al. (2023) in the Journal of Oral and Maxillofacial Pathology demonstrated that J. regia bark extract exhibited synergistic antimicrobial effects with commonly used antibiotics against initial plaque colonizers including Streptococcus mutans (PMID 38033951). Qayoom et al. (2023) in Saudi Journal of Biological Sciences used network pharmacology to elucidate the anticancer mechanism of juglanthraquinone C from walnut, identifying ESR1, AKT1, and TNF as key molecular targets in breast cancer pathways (PMID 37425621).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Macronutrients: Alpha-linolenic acid (ALA) (Omega-3), dietary fiber, protein. - Vitamins: Vitamin E, B vitamins (folate, vitamin B6). - Minerals: Magnesium, phosphorus, copper, manganese. - Phytochemicals: Polyphenols, flavonoids, melatonin.
Reported Mechanism (Provisional)
Kashmir walnut's polyphenolic compounds—ellagic acid, gallic acid, quercetin, and juglone—exert antioxidant activity primarily by chelating ferrous (Fe²⁺) ions and quenching hydroxyl radicals, thereby interrupting Fenton-reaction-driven lipid peroxidation in cell membranes. Walnut-derived peptides with molecular weights under 3 kDa exhibit dipeptidyl peptidase-IV (DPP-IV) inhibitory activity (notably the peptide sequence KGHLFPN), prolonging incretin hormone half-life and supporting glycemic regulation. The gut microbiome converts walnut ellagitannins into urolithin A, which crosses the blood-brain barrier and upregulates the PKA/CREB/BDNF signaling cascade, promoting neuronal survival and synaptic plasticity. Network pharmacology analysis has further identified juglanthraquinone C as a multi-target ligand interacting with ESR1, AKT1, MAPK1, and TNF receptors, modulating PI3K/AKT and MAPK/ERK pathways relevant to anti-inflammatory and anticancer responses (Qayoom et al., 2023; PMID 37425621).
Clinical Narrative (Provisional)
Current research on Kashmir walnut bioactivity is primarily limited to in vitro cellular studies and animal models rather than human clinical trials. Laboratory studies demonstrate antioxidant, hepatoprotective, and antimicrobial properties of walnut polyphenols, with some compounds showing stronger liver protection than curcumin in animal models. Specific compounds like Tellimagradin I and II show triglyceride-lowering effects in Type II diabetes animal models. However, quantified clinical trial data with specific sample sizes and measured outcomes in human subjects is lacking, representing a significant evidence gap.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.